Allspring Global Investments
EXAS

Allspring Global Investments’s Exact Sciences EXAS Stock Holding History

Allspring Global Investments’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-996
Closed -$67.8K – 1979
2024
Q3 		$67.8K Sell
996
-1,175
-54% -$66.3K ﹤0.01% 1820
2024
Q2 		$91.7K Sell
2,171
-502,240
-100% -$27.6M ﹤0.01% 1866
2024
Q1 		$34.8M Sell
504,411
-1,353,969
-73% -$85.6M 0.05% 423
2023
Q4 		$137M Buy
1,858,380
+192,372
+12% +$12.6M 0.23% 104
2023
Q3 		$114M Buy
1,666,008
+133,945
+9% +$11.4M 0.2% 114
2023
Q2 		$144M Buy
1,532,063
+620,592
+68% +$48.4M 0.23% 100
2023
Q1 		$61.8M Buy
911,471
+442,597
+94% +$28.4M 0.1% 264
2022
Q4 		$23.2M Buy
+468,874
New +$19.2M 0.04% 536
2022
Q1 		– Sell
-293
Closed -$22K – 3029
2021
Q4 		$22K Buy
+293
New +$25.9K ﹤0.01% 2895

Other funds holding EXAS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Allspring Global Investments's EXAS Position: Q4 2024 in Review

Allspring Global Investments sold out of Exact Sciences (EXAS) in Q4 2024, closing a stake of 996 shares — an estimated $67.8K sold.

Allspring Global Investments first reported a position in EXAS in Q4 2021 and held it in 9 quarters. The position peaked at $144M in Q2 2023. 594 funds tracked by Wall St. Rank hold EXAS as of Q4 2024.

  • Allspring Global Investments reported no remaining Exact Sciences position as of Q4 2024 after selling out during the quarter.
  • Allspring Global Investments sold 996 Exact Sciences shares in Q4 2024, an estimated $67.8K.
  • Allspring Global Investments first reported a position in Exact Sciences in Q4 2021 and held it in 9 quarters.
  • Allspring Global Investments's Exact Sciences position peaked at $144M in Q2 2023.
  • 594 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2024.

Based on Allspring Global Investments's 13F filing for Q4 2024, filed 29 Jan 2025.